Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QRFPR | Q96P65 | 5/20 | 0.42 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.42 |
| ▸ | TACR1 | P25103 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.35 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21782007 | 0.80 | C3AR1 (0.37) | QRFPRC3AR1 | |
| SCHEMBL21781895 | 0.77 | SIRT2 (0.33) | QRFPR | |
| SCHEMBL22593910 | 0.74 | TRPV1 (0.46) | QRFPRSMN1; SMN2 | |
| SCHEMBL22561383 | 0.74 | F7 (0.44) | SMN1; SMN2 | |
| SCHEMBL21782008 | 0.73 | CHRNB2 (0.44) | CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL21782107 | 0.73 | F7 (0.45) | SMN1; SMN2 | |
| SCHEMBL22593891 | 0.73 | TRPV1 (0.45) | — | |
| SCHEMBL22593908 | 0.72 | TRPV1 (0.46) | — | |
| SCHEMBL21649652 | 0.72 | SIRT1 (0.42) | CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL24240408 | 0.70 | SIRT2 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3617221-A1 | CYTOTOXIN AND CONJUGATE, USES OF SAME, AND PREPARATION METHOD THEREFOR | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) | 2020-03-04 | — | — | EP | disclosed |